'The effect of neuropeptide Y1 receptor agonist on hypothalamic neurogenesis in rat experimental depression model'
- PMID: 39576364
- DOI: 10.1007/s11011-024-01445-1
'The effect of neuropeptide Y1 receptor agonist on hypothalamic neurogenesis in rat experimental depression model'
Abstract
Depression is responsible for neuropathies such as decreased neurogenesis and increased dendritic atrophy. There is information that antidepressant treatments have an effect by increasing hippocampal neurogenesis and neurotrophic factor expression. The neuropeptide Y1 (NPY1R) receptor agonist has been suggested to have anxiolytic effects. Based on this information, it was aimed to investigate the effect of NPY1R agonist on depression in rats with depression using the CMS model and to determine how depression affects cell proliferation in the hypothalamus and hypothalamic peptide levels. Forty-eight adult, male Wistar albino rats were divided into groups as Control, Depression (D), Depression + NPY1R and NPY1R. Various stressors were applied to D for 30 days. An open field test (OFT) and forced swim test (FST) were performed to check whether the animals were depressed. On the 16th day, an osmotic mini pump was placed under the skin and NPY1R (130 ul/kg/day) was applied for 15 days. Behavioral tests were performed, hypothalamic peptide gene expression levels were analyzed by quantitative RT-PCR and statistical evaluations were made using ANOVA. A decrease in the percentage of movement in the D and control groups were noted in the OFT, an increase in the immobility time in the D group in the FST, and an increase in swimming behavior in the DNPY1R group. The animals did not display any anxiety behavior based on the elevated plus maze test results. It caused a decrease in IGF1R, FGF2, POMC, NPY and GLUT2 gene expression in the hypothalamus of depression group animals, and an increase in NPY gene expression in NPY1R treatment. This study compellingly demonstrated that exposure to chronic mild stress simultaneously downregulates gene expression in the hypothalamus; we observed that NPY receptor NPY1R treatment increased the effect of NPY. Therefore, adjunctive treatments with appropriate molecules such as NPY, Y1 receptor agonists or pharmacological derivatives may have significant potential in the treatment of depression.
Keywords: Chronic mild stress; Depression; Hypothalamus; Neurogenesis; Neuropeptide Y receptor 1.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Compliance with ethical standards. This study protocol was approved by the Experimental Animals Local Ethics Committee of Necmettin Erbakan University Experimental Medicine Application and Research Center. Consent for participate: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Does Sertraline Affect Hypothalamic Food Intake Peptides in the Rat Experimental Model of Chronic Mild Stress-Induced Depression?Neurochem Res. 2022 May;47(5):1299-1316. doi: 10.1007/s11064-022-03529-9. Epub 2022 Jan 26. Neurochem Res. 2022. PMID: 35080689
-
Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.Peptides. 2013 Sep;47:7-11. doi: 10.1016/j.peptides.2013.04.018. Epub 2013 Jun 28. Peptides. 2013. PMID: 23816796
-
Long-term enhancements in antidepressant efficacy and neurogenesis: Effects of intranasal co-administration of neuropeptide Y 1 receptor (NPY1R) and galanin receptor 2 (GALR2) agonists in the ventral hippocampus.FASEB J. 2024 Apr 15;38(7):e23595. doi: 10.1096/fj.202400087R. FASEB J. 2024. PMID: 38572811
-
Role of hypothalamic neuropeptide Y in feeding and obesity.Neuropeptides. 1999 Oct;33(5):329-38. doi: 10.1054/npep.1999.0057. Neuropeptides. 1999. PMID: 10657510 Review.
-
[18F]Y1-973.2012 Oct 30 [updated 2013 Feb 14]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2012 Oct 30 [updated 2013 Feb 14]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 23427353 Free Books & Documents. Review.
References
-
- Alizadeh Pahlavani H (2024) Possible role of exercise therapy on depression: Effector neurotransmitters as key players. Behav Brain Res 459:114791. https://doi.org/10.1016/j.bbr.2023.114791 Epub 2023 Dec 2. PMID: 38048912
-
- Arrabal-Gómez C, Beltran-Casanueva R, Hernández-García A, Bayolo-Guanche JV, Barbancho-Fernández MA, Serrano-Castro PJ, Narváez M (2024) Enhancing cognitive functions and neuronal growth through NPY1R agonist and ketamine co-administration: evidence for NPY1R-TrkB Heteroreceptor complexes in rats. Cells 13(8):669. https://doi.org/10.3390/cells13080669 PMID: 38667284; PMCID: PMC11049095 - DOI - PubMed - PMC
-
- Bale R, Doshi G (2023) Cross talk about the role of Neuropeptide Y in CNS disorders and diseases. Neuropeptides 102:102388. https://doi.org/10.1016/j.npep.2023.102388 Epub 2023 Oct 24. PMID: 37918268 - DOI - PubMed
-
- Bambico FR, Nguyen N-T, Gobbi G (2009) Decline in seroton ergic fring activity and desensitization of 5-HT1A autorecep tors after chronic unpredictable stress. Eur Neuropsychophar Macol 19:215–228. https://doi.org/10.1016/j.euroneuro.2008 - DOI
-
- Beltran-Casanueva R, Hernández-García A, Serrano-Castro PJ, Sánchez-Pérez JA, Barbancho-Fernández MA, García-Casares N, Fuxe K, Borroto-Escuela DO, Narváez M (2024) Long-term enhancements in antidepressant efficacy and neurogenesis: Effects of intranasal co-administration of neuropeptide Y 1 receptor (NPY1R) and galanin receptor 2 (GALR2) agonists in the ventral hippocampus. FASEB J 38(7):e23595. https://doi.org/10.1096/fj.202400087R - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous